IP Library Granted Patent US 10,947,282
Granted Patent B2
US 10,947,282 · App. 15/544,216 · Granted Mar 16, 2021

Functionalized protein-based materials and their uses

Inventors: Sarah Bondos (College Station, TX); Kayla Bayless (Bryan, TX); Kathleen Matthews (Houston, TX); Jan Patterson (College Station, TX); Colette Abbey (College Station, TX); David Howell (College Station, TX); Hao-Ching Hsiao (San Diego, CA); Kelly Churion (College Station, TX); Shang-Pu Tsai (Brookline, ME); Sandhya Ramasamy (Katy, TX); Dustin Porterpan (Kingwood, TX); Keira Northern (Houston, TX)
Assignees: The Texas A & M University System; William Marsh Rice University
C07K14/43581A61K9/70A61K9/7007A61K38/08A61K38/16A61K38/1767A61K38/1825A61K38/1866A61K38/195
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,947,282
App. No.
15/544,216
Granted
Mar 16, 2021
Kind
B2
Abstract

Embodiments of the invention are directed to Ubx-fusion molecules that maintain their mechanical strength and properties even after being fused with Ubx. Ubx fusions with VEGF and other growth factors, cell signaling proteins, and cell binding proteins can be used to induce angiogenesis. Ubx fibers and mesh, embedded within a tissue engineering scaffold, induce formation of vasculature within the scaffold. The presence of vasculature is necessary to provide oxygen and nutrients to other cells growing within the scaffold.

Claims (19)

1. A composition comprising at least one Ultrabithorax (Ubx) protein coupled with a first biomolecule, wherein the first biomolecule is a multimeric protein and is not Ubx, wherein the Ubx protein contains mutations within tyrosine residues involved in the formation of di-tyrosine bonds wherein the mutations within tyrosine residues influence formation of di-tyrosine bonds, alter the strength of Ubx materials, and/or alter intensity of blue fluorescence.

2. The composition of claim 1 , further comprising a second biomolecule.

3. The composition of claim 2 , wherein the second biomolecule is a highly soluble protein or an additional functional protein.

4. The composition of claim 1 , wherein the Ubx protein contains mutations within tyrosine residues that are not involved in the formation of di-tyrosine bonds.

5. The composition of claim 1 , wherein the dityrosine content is lower than in the wild type protein.

6. The composition of claim 1 , wherein the dityrosine content is greater than in the wild type protein.

7. The composition of claim 1 , wherein the first biomolecule is VEGF, FGF or SDF-1.

8. The composition of claim 1 , wherein the composition is incorporated into a structure.

9. The composition of claim 8 , wherein the structure is a mesh, film, fiber or a combination thereof.

10. The composition of claim 8 , wherein the structure is coated with a protein.

11. The composition of claim 10 , wherein the protein promotes angiogenesis.

12. The composition of claim 10 , wherein the protein activates a signaling pathway.

13. The composition of claim 12 , wherein the signaling pathway is the VEGF signaling pathway.

14. The composition of claim 8 , wherein the structure is coupled with DNA.

15. The composition of claim 1 , wherein the Ubx protein is selected from the group consisting of the full length Ubx protein, SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4.

16. The composition of claim 1 , wherein the Ubx protein is selected from the group consisting of the combination of SEQ ID NO: 1 and SEQ ID NO: 2 and the combination of SEQ ID NO: 3 and SEQ ID NO: 4.

17. A composition comprising at least one Ultrabithorax (Ubx) protein coupled with a first biomolecule, wherein the first biomolecule is a multimeric protein and is not Ubx, wherein the Ubx protein is selected from the group consisting of the full length Ubx protein, SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4, and wherein the Ubx protein contains mutations within tyrosine residues involved in the formation of di-tyrosine bonds.

18. The composition of claim 17 wherein the mutations within tyrosine residues influence formation of di-tyrosine bonds, alter the strength of Ubx materials, or alter intensity of blue fluorescence.

19. A composition comprising at least one full-length ultrabithorx (Ubx) protein with substitutions within tyrosine residues involved in the formation of di-tyrosine bonds coupled with a first multimeric biomolecule which is not Ubx.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2018
From: MATTHEWS, KATHLEEN
To: WILLIAM MARSH RICE UNIVERSITY
Reel/Frame 046047/0871 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY PREVIOUSLY RECORDED AT REEL: 044780 FRAME: 0033. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jun 11, 2018
From: BONDOS, SARAH; BAYLESS, KAYLA; PATTERSON, JAN; ABBEY, COLETTE; HOWELL, DAVID; HSIAO, HAO-CHING; CHURION, KELLY; TSAI, SHANG-PU; RAMASAMY, SANDHYA; PORTERPAN, DUSTIN; NORTHERN, KEIRA
To: THE TEXAS A&M UNIVERSITY SYSTEM
Reel/Frame 046335/0659 →
CONFIRMATORY LICENSE Recorded Apr 9, 2018
From: TEXAS A&M UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045865/0760 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2018
From: BONDOS, SARAH; BAYLESS, KAYLA; MATTHEWS, KATHLEEN; PATTERSON, JAN; ABBEY, COLETTE; HOWELL, DAVID; HSIAO, HAO-CHING; CHURION, KELLY; TSAI, SHANG-PU; RAMASAMY, SANDHYA; PORTERPAN, DUSTIN; NORTHERN, KEIRA
To: THE TEXAS A&M UNIVERSITY SYSTEM
Reel/Frame 044780/0033 →
Continuity (2)
Provisional Application 62105132 · Jan 19, 2015
Related Publication 20180222949A1 · Aug 9, 2018
Cited By (1)
US 12,275,765